PARP1 is heavily automodified upon bacterial infection (96) and Parp1−/− mice have proven to be resistant to inflammation in different experimental models, such as LPS-induced septic shock and streptozotocin-induced diabetes (97, 98). Here, PARP1 is linked to bacterial infectious disease.